Between Dec 19, 2024 and Jan 2, 2025, datasets can be submitted to DRUM but will not be processed until after the break. Staff will not be available to answer email during this period, and will not be able to provide DOIs until after Jan 2. If you are in need of a DOI during this period, consider Dryad or OpenICPSR. Submission responses to the UDC may also be delayed during this time.

Browsing by Subject "Micro-CT"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Computational Modeling of Cardiac Devices Implanted in Specimens Preserved within the Visible Heart® Laboratories’ Human Heart Library
    (2022-01) Cham, Nyimatoulie
    The Visible Heart® Laboratories’ (VHL) Atlas of Cardiac Anatomy is an open public resource to students, medical professionals, and individuals in medical device companies that contains expansive cardiac anatomy and physiology information. Within this website is the human heart library, which contains 835 specimens overall, including perfusion-fixed and pre-fixed specimens collected from the Advanced Cardiac Anatomy and Physiology Course, as well as donated hearts received from LifeSource. The physical specimens are housed within the VHL (Minneapolis, Minnesota), and individuals that utilize the library can take pictures, make measurements, and perform device draping studies as long as these procedures are non-destructive. In this project, the main aim was to identify heart specimens within the VHL human heart library and build a database of the hearts that had associated implanted cardiac devices within. With the successful imaging of a large number of hearts with a variety of cardiac devices, these images will be made available on the free-access Atlas of Human Cardiac Device website: this will include photos and unity flythrough movies, as well as the resultant generated computational models.
  • Thumbnail Image
    Item
    Utility of the Visible Heart® and Micro-CT Imaging to Optimize the Treatments of Bifurcation Stenting
    (2021-05) Valenzuela, Thomas
    Using the Visible Heart® Apparatus and methodologies allows for the ability to reanimate large mammalian hearts, including human, and thus to perform bifurcation stenting in an in vitro setting. This allows for novel uses of multimodal imaging for assessing/testing previous, current and future clinical recommendations for bifurcation techniques, without risking a living patient. After performing such procedures, high resolution 3D models were obtained via micro-CT imaging, which then allows for post implant device/tissue interface analyses. Utilizing reanimated swine hearts, we were able to uniquely visualize how the various bifurcation techniques performed could be optimized in specific anatomies. These findings again confirm that the Visible Heart® Apparatus is a valuable platform that should be used to further understand how next generation stents and/or bifurcation techniques can best be utilized. Recently, our laboratory also had the privilege to perform bifurcation stenting within three reanimated human hearts using the same methodologies. Additionally, similar PCI procedures were performed in three perfusion-fixed human hearts as further means to compare the differences in stenting technique and to identify potential differences between procedures performed in fixed versus reanimated human hearts. Also, it was identified that after the formalin fixation process, desecrations of the coronary vessels could readily be induced in healthy human hearts, while those presenting with coronary artery disease elicited little to no effects due to the plaque formations. If this holds true, this will open the Visible Heart® Laboratories’ human heart library of over 580 specimens, to perform clinically relevant bifurcation stenting techniques. Finally, a novel research method of detecting stent malappositions was created, as the current standard for intracoronary imaging, optical coherence tomography (OCT), has its limitations when there are multiple stents implanted. This method was then used alongside OCT in a step-by -step bifurcation intervention performed in a formalin fixed human heart. It was shown that stent apposition continuously improves if the operator adheres to the latest published guidelines; however future investigations should be performed in more diseased human hearts from the Visible Heart’s human heart library to focus on other bifurcation techniques and the consequences of straying from these guidelines in each case.